Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide Pharmacogenomics in Obese Patients
NCT04839237Phase 2Withdrawn
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Dec 2017
- Primary completion
- Dec 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in obesity, sponsored by Xiangya Hospital, Central South University. Planned start Dec 2017; status: withdrawn.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04839237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04839237.